REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 86 filers reported holding REGENXBIO INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,038,392 | -17.0% | 4,376,573 | +0.8% | 0.00% | 0.0% |
Q2 2023 | $86,757,439 | +6.3% | 4,340,042 | +0.5% | 0.00% | 0.0% |
Q1 2023 | $81,634,867 | -15.8% | 4,317,021 | +1.0% | 0.00% | -33.3% |
Q4 2022 | $96,900,165 | -14.1% | 4,272,494 | +0.1% | 0.00% | 0.0% |
Q3 2022 | $112,792,000 | +7.4% | 4,267,542 | +0.4% | 0.00% | 0.0% |
Q2 2022 | $105,033,000 | -22.3% | 4,252,323 | +4.5% | 0.00% | 0.0% |
Q1 2022 | $135,099,000 | +1.9% | 4,070,462 | +0.4% | 0.00% | 0.0% |
Q4 2021 | $132,565,000 | -21.1% | 4,053,966 | +1.1% | 0.00% | -25.0% |
Q3 2021 | $168,064,000 | +9.7% | 4,009,182 | +1.7% | 0.00% | 0.0% |
Q2 2021 | $153,215,000 | +14.1% | 3,943,759 | +0.2% | 0.00% | 0.0% |
Q1 2021 | $134,265,000 | -11.3% | 3,936,232 | +18.0% | 0.00% | 0.0% |
Q4 2020 | $151,289,000 | +69.3% | 3,335,298 | +2.7% | 0.00% | +33.3% |
Q3 2020 | $89,361,000 | -29.7% | 3,247,098 | -5.9% | 0.00% | -40.0% |
Q2 2020 | $127,077,000 | +10.7% | 3,450,367 | -2.7% | 0.01% | 0.0% |
Q1 2020 | $114,784,000 | -18.1% | 3,544,905 | +3.6% | 0.01% | 0.0% |
Q4 2019 | $140,163,000 | +23.4% | 3,421,100 | +7.2% | 0.01% | +25.0% |
Q3 2019 | $113,625,000 | -35.9% | 3,191,703 | -7.5% | 0.00% | -42.9% |
Q2 2019 | $177,220,000 | -9.2% | 3,449,874 | +1.3% | 0.01% | -12.5% |
Q1 2019 | $195,164,000 | +37.3% | 3,405,422 | +0.5% | 0.01% | +33.3% |
Q4 2018 | $142,132,000 | -32.9% | 3,388,104 | +20.7% | 0.01% | -25.0% |
Q3 2018 | $211,851,000 | +58.9% | 2,805,969 | +51.0% | 0.01% | +33.3% |
Q2 2018 | $133,332,000 | +247.7% | 1,858,298 | +44.7% | 0.01% | +200.0% |
Q1 2018 | $38,345,000 | -5.7% | 1,284,580 | +5.1% | 0.00% | 0.0% |
Q4 2017 | $40,656,000 | +1.7% | 1,222,720 | +0.8% | 0.00% | 0.0% |
Q3 2017 | $39,962,000 | +86.9% | 1,212,798 | +12.0% | 0.00% | +100.0% |
Q2 2017 | $21,379,000 | +12.9% | 1,082,461 | +10.3% | 0.00% | 0.0% |
Q1 2017 | $18,942,000 | +28.2% | 981,517 | +23.2% | 0.00% | 0.0% |
Q4 2016 | $14,781,000 | +37.7% | 796,817 | +4.0% | 0.00% | 0.0% |
Q3 2016 | $10,736,000 | +135.5% | 766,315 | +34.5% | 0.00% | – |
Q2 2016 | $4,559,000 | +60.3% | 569,935 | +116.4% | 0.00% | – |
Q1 2016 | $2,844,000 | -15.7% | 263,339 | +29.5% | 0.00% | – |
Q4 2015 | $3,375,000 | +411.4% | 203,322 | +578.5% | 0.00% | – |
Q3 2015 | $660,000 | – | 29,966 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |